Navigation Links
Therapy slows onset and progression of Lou Gehrig's disease, study finds
Date:9/9/2013

Studies of a therapy designed to treat amyotrophic lateral sclerosis (ALS) suggest that the treatment dramatically slows onset and progression of the deadly disease, one of the most common neuromuscular disorders in the world. The researchers, led by teams from The Research Institute at Nationwide Children's Hospital and the Ludwig Institute at the University of California, San Diego, found a survival increase of up to 39 percent in animal models with a one-time treatment, a crucial step toward moving the therapy into human clinical trials.

The therapy reduces expression of a gene called SOD1, which in some cases of familial ALS has a mutation that weakens and kills nerve cells called motor neurons that control muscle movement. While many drug studies involve only one type of animal model, this effort included analysis in two different models treated before and after disease onset. The in-depth study could vault the drug into human clinical trials, said Brian Kaspar, PhD, a principal investigator in the Center for Gene Therapy at Nationwide Children's and a senior author on the research, which was published online Sept. 6 in Molecular Therapy.

"We designed these rigorous studies using two different models of the disease with the experimenters blinded to the treatment and in two separate laboratories," said Dr. Kaspar, who collaborated on the study with a team led by Don Cleveland, PhD, at the University of California, San Diego. "We were very pleased with the results, and found that the delivery approach was successful in a larger species, enabling us to initiate a clinical translational plan for this horrible disease."

There currently is no cure for ALS, also called Lou Gehrig's disease. The Centers for Disease Control and Prevention estimates there are about 5,000 new cases in the U.S. each year, mostly in people age 50 to 60. Although the exact cause of ALS is unknown, more than 170 mutations in the SOD1 gene have been fou
'/>"/>

Contact: Gina Bericchia
Gina.Bericchia@NationwideChildrens.org
614-355-0495
Nationwide Children's Hospital
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Physiotherapy in Singapore Clinic Urbanrehab Pte Ltd Announces the Opening of an Additional Location
2. Chemotherapy before radiotherapy for testicular cancer could reduce long-term side-effects
3. ITN type 1 diabetes study identifies subset of patients with strong response to therapy
4. Combined therapy could repair and prevent damage in Duchenne muscular dystrophy
5. Study suggests way to fight therapy resistant leukemia by blocking DNA repair
6. An effective initial polytherapy for infantile spasms
7. UCLA stem cell gene therapy for sickle cell disease advances toward clinical trials
8. Neuroblastoma: Autophagy protects from chemotherapy
9. Dendritic cell therapy improves kidney transplant survival, Pitt team says
10. No danger of cancer through gene therapy virus
11. An article in Cell reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2015)... 13, 2015 According to ... Biometrics Market Forecast & Opportunities, 2020", the global biometrics ... around 14% till 2020. The biometrics market is ... implementation and review of biometric management systems. The ... products with greater efficiency, are resulting in increasing ...
(Date:4/8/2015)... , April 8, 2015  Infinisource, a ... and services, and Morpho, a leading supplier of ... to produce the market,s most advanced biometrically-enabled time ... iSolved NXG time clock is setting a bold, ... labor data for the small and mid-size employer. ...
(Date:4/2/2015)... -- According to preliminary estimates Fingerprint Cards, ... than 125 MSEK. This exceeds the guidance provided by ... for Q1 2015 would be in line with the ... The operating result for the first quarter is estimated ... will as previously communicated be published on May 21. ...
Breaking Biology News(10 mins):Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3Fingerprint Cards Revises Revenues for Q1 2015 2
... could help make DNA sequencing affordable enough for clinics ... Andrew Smith, a computational biologist at the USC Dornsife College ... USC graduate student Timothy Daley to help predict the value ... Methods on February 24. Extracting information from ...
... The Children,s Medical Center Research Institute at ... environment within bone marrow that nurtures stem cells, this ... that produce the infection-fighting white blood cells known as ... that cells called early lymphoid progenitors, which are responsible ...
... Bahrami will use his expertise in cooling and heating ... to develop green air conditioning and refrigeration systems (AC-R) ... service vehicle and long-haul truck idling engines. With ... Partnership Canada, the associate professor in Mechatronic Systems Engineering ...
Cached Biology News:Taking the gamble out of DNA sequencing 2Scientists find bone-marrow environment that helps produce infection-fighting T and B cells 2Clean energy research targets idle engines 2Clean energy research targets idle engines 3
(Date:4/17/2015)... CIO Review ( http://www.cioreview.com ) has ... Promising Pharma and Life Science Technology Solution Providers 2015. ... software platform for life sciences companies. , The ... of experts and members of CIO Review’s editorial board ... has been on our radar for some time now ...
(Date:4/17/2015)... -- Guggenheim Securities, the investment banking and capital markets division ... William Tanner as a Managing Director and senior ... work at Guggenheim in May 2015 in the firm,s ... "Bill brings a wealth of biotech experience, in both ... acclaimed healthcare team," said Matthew Johnson , Senior ...
(Date:4/17/2015)... 17, 2015 Global Stem Cells ... Stem Cell Summit 2015 April 27 - 29, 2015 ... developments in all areas of stem cell research including ... cells and regenerative medicine. , The conference will ... well as translational research in stem cell therapies, regenerative ...
(Date:4/17/2015)... April 17, 2015 BellBrook Labs ... marketing support for the powerful Orthogonal Pooled Screening ... Genomics Center at the Lankenau Institute for Medical ... is to measurably improve successful drug discovery outcomes ... offering rare, drug-like libraries available nowhere else, coupled ...
Breaking Biology Technology:MMIS Chosen by CIO Review as Top 20 Most Promising Pharma and Life Science Technology Solution Providers 2015 2Guggenheim Securities Hires Biotech Analyst William Tanner in Expansion of Healthcare Coverage 2Global Stem Cells Group To Join GTCbio Stem Cell and Regenerative Medicine Summit in Boston, April 27-29, 2015 2Global Stem Cells Group To Join GTCbio Stem Cell and Regenerative Medicine Summit in Boston, April 27-29, 2015 3BellBrook Labs and Lankenau Institute Partner to Accelerate Drug Discovery using Orthogonal Pooled Screening 2
... vital to the success of his or her business, and ... definitive answer. Finding and keeping the right employees, affording health ... are common replies. , ,Holding down taxes? That's on the ... order depends on the entrepreneur. Those who aren't yet turning ...
... one of our exclusive interview with new TDS Telecom ... in transforming TDS from a phone company to a broadband provider. ... to drive innovation, and explains why every TDS employee has a ... part one ) , , WTN: How would you describe ...
... address the lack of an effective delivery method in ... has entered into a two-year, multimillion dollar agreement with ... models. , ,Russell Smestad, president of Mirus Bio, said ... Achilles' heel that has impeded progress in RNA interference, ...
Cached Biology Technology:High taxes and low rates of entrepreneurship - is there a relationship? 2High taxes and low rates of entrepreneurship - is there a relationship? 3New CEO at TDS on creating a culture of innovation (Part 2) 2New CEO at TDS on creating a culture of innovation (Part 2) 3New CEO at TDS on creating a culture of innovation (Part 2) 4Mirus Bio, Pfizer enter multimillion-dollar research agreement 2
... with a modular approach to instrument control, ... Plus NDS family provides modular software components ... management, giving you the flexibility to choose ... now and that can grow as your ...
... solution is a highly scalable analysis ... data in a workgroup or an ... over 40 leading pharmaceutical, biotechnology, academic ... Workgroup streamlines genomics research at large ...
... scale kinase profiling, quantitative measurement of ... research built on the flexible and ... These microarrays are available as part ... - Peptide Microarray Service. ...
... 18 amino acid synthetic peptide whose sequences are derived from mouse ... carboxy terminus): S(21) - S - M - P - L ... A - I - D - K - K - I ... peptide may be used for neutralization and control experiments with the ...
Biology Products: